UK Medicines Information
Educational Risk Minimisation Guide to help reduce the risk associated with using Namuscla (mexiletine hydrochloride) capsules –
Information type:
Safety alerts
Source:
Lupin Healthcare
Specialities:
Cardiovascular system disorders | Liver disorders | Neurological disorders
Summary
This guide includes detailed advice on patient counselling, cardiac monitoring and reporting of adverse reactions; in order to help minimise the risks of cardiac arrhythmia and severity of adverse reactions in those with hepatic impairment.
UKMi comment
A new patient alert card is also available (link below)
Related links:
A new patient alert card